Literature DB >> 7033913

Encephalopathy of Reye's syndrome: a review of pathogenetic hypotheses.

G R DeLong, T H Glick.   

Abstract

The pathogenesis of Reye's syndrome encephalopathy was analyzed in terms of uniform criteria designed to clarify and assist evaluation of the leading hypotheses. Three of these hypotheses derive from known metabolic sequelae of hepatic mitochondrial dysfunction and the severe systemic catabolism of protein, fats, and carbohydrates that characterize the syndrome biochemically: hyperammonemia, hyperfattyacidemia, and hyperlactatemia. In addition, there is a fourth hypothesis of generalized mitochondrial insult affecting brain, muscle, and other organs as well as liver. The weight of evidence favors hyperammononemia as a sufficient factor while recognizing important interrelationships with the other observed biochemical derangements. How the catabolism and hepatic mitochondrial dysfunction are produced by the triggering viral infection remains unknown. Therapeutic efforts have thus far not succeeded in definitive metabolic intervention. Such reversal of the clinical syndrome would lead to confirmation of the necessary pathogenetic factors; this type of intervention remains the chief goal of metabolic research in Reye's syndrome.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7033913

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  14 in total

1.  Reye's syndrome with cortical laminar necrosis: MRI.

Authors:  T Kinoshita; S Takahashi; K Ishii; S Higano; K Matsumoto; K Sakamoto; K Haginoya; K Iinuma
Journal:  Neuroradiology       Date:  1996-04       Impact factor: 2.804

Review 2.  Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.

Authors:  J Osterloh; W Cunningham; A Dixon; D Combest
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

3.  The prognosis of Reye's syndrome in Ireland. Can it be improved.

Authors:  J F Glasgow; J G Jenkins; E M Hicks; S R Keilty; P M Crean; G W Black; T F Fannin
Journal:  Ir J Med Sci       Date:  1986-04       Impact factor: 1.568

4.  Defects of metabolism of fatty acids in the sudden infant death syndrome.

Authors:  A J Howat; M J Bennett; S Variend; L Shaw; P C Engel
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-15

5.  Metabolic and mitochondrial morphological changes that mimic Reye syndrome after endotoxin administration to rats.

Authors:  M C Yoder; J M Egler; M Yudkoff; J Chatten; S D Douglas; R A Polin
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

6.  Aetiology of Reye's syndrome.

Authors:  M H Bellman; S M Hall
Journal:  Arch Dis Child       Date:  1983-09       Impact factor: 3.791

7.  Deficiency of medium chain fatty acylcoenzyme A dehydrogenase presenting as the sudden infant death syndrome.

Authors:  A J Howat; M J Bennett; S Variend; L Shaw
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-31

8.  Acute necrotizing encephalopathy of childhood: correlation of MR findings and clinical outcome.

Authors:  A M Wong; E M Simon; R A Zimmerman; H-S Wang; C-H Toh; S-H Ng
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

9.  Serum lipid abnormalities in a chemical/viral mouse model for Reye's syndrome.

Authors:  M G Murphy; L Archambault-Schertzer; R G Ackman; J F Crocker
Journal:  Lipids       Date:  1986-06       Impact factor: 1.880

10.  A child with acute pancreatitis and recurrent hypoglycemia due to 3-hydroxy-3-methylglutaryl-CoA lyase deficiency.

Authors:  W G Wilson; M B Cass; O Søvik; K M Gibson; L Sweetman
Journal:  Eur J Pediatr       Date:  1984-09       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.